RHYTHM PHARMACEUTICALS, INC. — Director's Dealing 2019

Jan 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK: 0001649904
Period of Report: 2019-01-16

Reporting Person: Gottesdiener Keith Michael (Director, CEO & President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-16	Common Stock	S	662	$30.00	Disposed	570814	Direct

Footnotes

F1: On January 16, 2019, Mr. Gottesdiener sold 662 shares pursuant to a plan of disposition adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

F2: This transaction was executed in multiple trades at prices ranging from $30.00 to $30.02, inclusive; the price reported above reflects the weighted average sale price. Mr. Gottesdiener hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.